findmyKOL
Clinical trialNCT02055924TerminatedPhase 1Interventional

Bruton's Tyrosine Kinase (BTK) Inhibition in B-cell Lymphomas

SponsorThe Lymphoma Academic Research OrganisationEnrollment85B-cell Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium
  • Universite Catholique de Louvain Saint Luc

    Brussels, Belgium

  • Chu de Liège

    Liège, Belgium

  • Chu Ucl Namur Asbl

    Yvoir, Belgium

France
  • Centre François Baclesse

    Caen, France

  • Hôpital Henri Mondor

    Créteil, France

  • Chu de Dijon - Hôpital Le Bocage

    Dijon, France

  • Chru de Lille - Hôpital Claude Huriez

    Lille, France

  • Centre Léon Bérard

    Lyon, France

  • Chu Montpellier

    Montpellier, France

  • Chu de Nantes

    Nantes, France

  • Hôpital Saint Louis

    Paris, France

  • Centre François Magendie - Hôpital Du Haut Lévêque

    Pessac, France

  • Centre Hospitalier Lyon Sud

    Pierre-Bénite, France

  • Chu Pontchaillou

    Rennes, France

  • Centre Henri Becquerel

    Rouen, France

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
26 May 2014
Primary completion
1 Dec 2017
Completion
9 Oct 2018
Last update posted
11 Oct 2018
Registered enrollment
85
Registry id
NCT02055924

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.